Merger Fairness Probes
Legal Firm Ademi Probes Major Mergers For Shareholder Value Concerns
Anonymous
Key Points
1
Huntsman (HUN) shareholders will receive 0.5476 shares of Olin (OLN) for every Huntsman share, resulting in roughly 54.5% ownership for the combined company by Olin shareholders and 45.5% by Huntsman shareholders.
2
The Fathom Holdings (FTHM) and Bed Bath & Beyond (BBBY) deal is all-stock, with Fathom shareholders receiving 0.2236 shares of BBBY for each Fathom share, in a transaction valued at approximately $53.38 million.
3
Nuvalent (NUVL) and GSK plc (GSK) would transact at $124 per Nuvalent share, valuing the deal at about $10.6 billion in aggregate equity value.
4
Roku (ROKU) and Fox (FOXA) propose a cash-and-stock deal valued at $160 per Roku share, with Fox paying $96 in cash and 0.9693 shares of Fox Class A for each Roku share; post-close ownership would be about 73% Fox and 27% Roku.
5
Payoneer (PAYO) shareholders are to receive $7.40 in cash per share in the proposed sale to Nuvei, totaling roughly $2.75 billion in equity value.
Shareholder rights firm Ademi LLP launched five separate investigations on July 2, 2026, targeting major merger deals worth a combined tens of billions of dollars StreetInsider. The firm claims boards at Huntsman, Roku, Nuvalent, Payoneer, and Fathom Holdings may have shortchanged public shareholders by accepting deals that lock out competing bids.
The probes cover a wide range of industries — chemicals, media, pharma, fintech, and real estate tech — and come amid a broader wave of corporate consolidation that has accelerated through mid-2026 Globe Newswire. In every case, Ademi points to change-of-control payouts to insiders and financial penalties designed to deter rival buyers.
Five Deals, Five Investigations Launched in One Day
Ademi LLP, led by attorney Guri Ademi, filed all five alerts on the same day. The firm argues that each board may have breached its fiduciary duty — the legal obligation to act in shareholders' best interest. Ademi says the deals may "unreasonably limit competing transactions" by including steep termination fees StreetInsider.
The largest target is the Fox-Roku deal, valued at $22 billion. Fox would pay $96 in cash plus 0.9693 Fox Class A shares for each Roku share, totaling $160 per share CBS News. The smallest is Fathom Holdings' all-stock deal with Bed Bath & Beyond, worth just $53.38 million. Fathom shareholders would get 0.2236 BBBY shares per share they hold.
Termination Fees and Insider Payouts Raise Red Flags
Ademi zeroes in on one specific concern across all five deals: termination fees. In the Huntsman-Olin merger, a $121 million breakup fee would kick in if Huntsman walked away for a better offer Stock Titan. Critics argue fees like this discourage rival bidders and effectively "lock up" the deal before shareholders can weigh in.
Change-of-control arrangements are also in focus. These are executive compensation packages triggered by a merger — meaning top insiders can walk away with large payouts even if shareholders lose out. Ademi says these create a conflict of interest: executives may prefer a done deal over a better price for public investors PR Newswire.
A Deal-Making Frenzy Across Chemicals, Pharma, and Media
The five deals were announced in rapid succession between June 9 and June 17, 2026. GSK kicked things off on June 9 with a $10.6 billion all-cash bid for cancer biotech Nuvalent at $124 per share Investing.com. GSK justified the roughly 40% premium by pointing to two Nuvalent cancer drugs with FDA Breakthrough designations.
On June 16, Olin and Huntsman announced an all-stock "merger of equals." Huntsman shareholders would get 0.5476 Olin shares per share, leaving Olin investors with 54.5% of the combined company SprayFoam Magazine. Huntsman CEO Peter Huntsman said the exchange ratio was based on a 30-day volume-weighted average price to ensure fairness. The next day, Bed Bath & Beyond announced it was buying real estate tech firm Fathom as part of what leader Marcus Lemonis calls an "Everything Home" strategy Housing Wire.
Markets Skeptical as Analysts Split on Deal Value
Investors pushed back quickly after some announcements. Fox shares fell 8% the day the Roku deal was revealed, while Roku shares rose but stayed well below the $160 offer price The Guardian. That gap signals the market doubts the Fox stock portion of the deal is worth what Fox claims. Payoneer shareholders face a simpler calculation: $7.40 per share in cash from Nuvei, totaling $2.75 billion PR Newswire.
Analysts are divided. Wolfe Research upgraded Fox to "Outperform," arguing the Roku deal would double Fox's long-term sales growth and that Fox was already trading 23% below pre-merger levels Investing.com. But Jefferies downgraded Roku to "Hold," noting the stock price is now capped by the acquisition offer. Ademi's probes add another layer of uncertainty — though the firm stresses these are investigations, not findings of wrongdoing.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
53
Reach
66
A
AnonymousAuthor
